Neuphoria Therapeutics Inc., a Delaware corporation, has successfully completed the redomiciliation process of Bionomics Limited, an Australian corporation, on December 23, 2024. This transformative ...
Neuphoria Therapeutics shares closed up in their first Nasdaq trading day after Bionomics re-domiciled to the U.S. from Australia and Neuphoria became the ultimate parent company of Bionomics. The ...
Neuphoria Therapeutics Inc. has completed its redomiciliation, transferring governance from Bionomics’ organizational documents to Neuphoria’s new Certificate of Incorporation and bylaws.
Neuphoria Therapeutics has successfully completed the re-domiciliation of Bionomics Limited, positioning itself as the ultimate parent company, which may enhance its strategic presence in the ...
Neuphoria Therapeutics Inc. (Nasdaq: NEUP) ("Neuphoria" or the "Company") is pleased to announce that its previously announced scheme of arrangement ...
As a global Partnership, we believe in internationalism. We have translated as much content in your language as our resources allow. Please visit the English language site to view all of our content.